litlas
ログインアカウント作成

James E. Balow

1973–2020 年に発表

別表記
JAMES E. BALOW
67
論文数
23,217
被引用数
66
h 指数
67
i10 指数

被引用数

James E. Balow の年別被引用数1974 年: 被引用 4 件1975 年: 被引用 1 件1976 年: 被引用 5 件1977 年: 被引用 1 件1978 年: 被引用 12 件1979 年: 被引用 17 件1980 年: 被引用 15 件1981 年: 被引用 18 件1982 年: 被引用 25 件1983 年: 被引用 21 件1984 年: 被引用 27 件1985 年: 被引用 20 件1986 年: 被引用 28 件1987 年: 被引用 22 件1988 年: 被引用 28 件1989 年: 被引用 32 件1990 年: 被引用 44 件1991 年: 被引用 26 件1992 年: 被引用 45 件1993 年: 被引用 48 件1994 年: 被引用 62 件1995 年: 被引用 60 件1996 年: 被引用 85 件1997 年: 被引用 65 件1998 年: 被引用 94 件1999 年: 被引用 106 件2000 年: 被引用 109 件2001 年: 被引用 133 件2002 年: 被引用 152 件2003 年: 被引用 157 件2004 年: 被引用 226 件2005 年: 被引用 159 件2006 年: 被引用 191 件2007 年: 被引用 183 件2008 年: 被引用 110 件2009 年: 被引用 194 件2010 年: 被引用 176 件2011 年: 被引用 149 件2012 年: 被引用 182 件2013 年: 被引用 120 件2014 年: 被引用 119 件2015 年: 被引用 118 件2016 年: 被引用 124 件2017 年: 被引用 117 件2018 年: 被引用 99 件2019 年: 被引用 370 件2020 年: 被引用 356 件2021 年: 被引用 305 件2022 年: 被引用 238 件2023 年: 被引用 139 件2024 年: 被引用 238 件2025 年: 被引用 101 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,896 件、この内訳の 29%イギリス: 引用元論文 461 件、この内訳の 7%ドイツ: 引用元論文 400 件、この内訳の 6.1%中国: 引用元論文 384 件、この内訳の 5.9%イタリア: 引用元論文 309 件、この内訳の 4.7%フランス: 引用元論文 289 件、この内訳の 4.4%カナダ: 引用元論文 241 件、この内訳の 3.7%オランダ: 引用元論文 214 件、この内訳の 3.3%スペイン: 引用元論文 194 件、この内訳の 3%日本: 引用元論文 193 件、この内訳の 2.9%オーストラリア: 引用元論文 138 件、この内訳の 2.1%スイス: 引用元論文 126 件、この内訳の 1.9%
0%29%その他 26%

機関

分野

  • Medicine66.4%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Immunology and Microbiology11.1%
  • Neuroscience1.5%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Computer Science0.3%
  • その他1.3%

トピック

  • Systemic Lupus Erythematosus Research11.4%
  • Renal Diseases and Glomerulopathies4.3%
  • Inflammasome and immune disorders3.2%
  • Lysosomal Storage Disorders Research3.2%
  • T-cell and B-cell Immunology3.1%
  • Renal Transplantation Outcomes and Treatments1.9%
  • その他72.9%

共著者

全論文

検索で開く
  1. The classification of glomerulonephritis in systemic lupus erythematosus revisited

    著者: Jan J. Weening, ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, L Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata - Kidney International 2004 被引用: 1,649

  2. The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

    著者: Jan J. Weening, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, Lee A. Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata - Journal of the American Society of Nephrology 2004 被引用: 1,998

  3. Enzyme Replacement Therapy in Fabry Disease

    著者: Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin, Sharda G. Sabnis, David F. Moore, Thais Weibel, James E. Balow, Roscoe O. Brady - JAMA 2001 被引用: 1,305

  4. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis

    著者: John C. Davis, S Manzi, Cheryl Yarboro, Joan E. Rairie, Iain B. McInnes, D Averthelyi, Dominick Sinicropi, Victoria Hale, James E. Balow, H A Austin, Dimitrios T. Boumpas, John H. Klippel - Lupus 1999 被引用: 233

  5. Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study

    著者: Gabor G. Illei, Yuko Shirota, Cheryl Yarboro, Jimmy Daruwalla, Edward Tackey, Kazuki Takada, Thomas A. Fleisher, James E. Balow, Peter E. Lipsky - Arthritis & Rheumatism 2010 被引用: 505

  6. A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis

    著者: Dimitrios T. Boumpas, Richard Furie, Susan Manzi, Gabor G. Illei, Daniel J. Wallace, James E. Balow, Akshay Vaishnaw, on behalf of the BG9588 Lupus Nephritis Trial Group - Arthritis & Rheumatism 2003 被引用: 617

  7. Therapy of Lupus Nephritis

    著者: Howard A. Austin, John H. Klippel, James E. Balow, Nicole G.H. Le Riche, Alfred D. Steinberg, Paul H. Plötz, John L. Decker - New England Journal of Medicine 1986 被引用: 1,196

  8. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseases

    著者: Ivona Aksentijevich, Miroslawa Nowak, Mustapha Mallah, Jae Jin Chae, Wendy T. Watford, Sigrun R. Hofmann, Leonard D. Stein, Ricardo Russo, Donald P. Goldsmith, Peter B. Dent, Helene F. Rosenberg, Frances Austin, Elaine F. Remmers, James E. Balow, Sergio D. Rosenzweig, Hirsh D. Komarow, Nitza G. Shoham, Geryl Wood, Janet H. Jones, Nadira Mangra, Hector Carrero, Barbara S. Adams, Terry L. Moore, Kenneth N. Schikler, Hal M. Hoffman, Daniel J. Lovell, Robert Lipnick, Karyl S. Barron, John J. O’Shea, Daniel L. Kastner, Raphaela Goldbach‐Mansky - Arthritis & Rheumatism 2002 被引用: 703

  9. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long‐term followup of a cohort of 145 patients participating in randomized controlled studies

    著者: Gabor G. Illei, Kazuki Takada, Donald Maxwell Parkin, H A Austin, Marianna Crane, Cheryl Yarboro, Ellen M. Vaughan, Takashi Kuroiwa, Carol L. Danning, José M. Morales-De Pando, A D Steinberg, M F Gourley, John H. Klippel, James E. Balow, Dimitrios T. Boumpas - Arthritis & Rheumatism 2002 被引用: 332

  10. Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations

    著者: Anthony S. Fauci, DAVID C. DALE, JAMES E. BALOW - Annals of Internal Medicine 1976 被引用: 1,048

  11. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome

    著者: Howard A. Austin, Larry R. Muenz, Kathleen Joyce, Tatiana T. Antonovych, James E. Balow - Kidney International 1984 被引用: 722

  12. Urinary exosomal transcription factors, a new class of biomarkers for renal disease

    著者: Hua Zhou, Anita Cheruvanky, Xuzhen Hu, Takayuki Matsumoto, Noriyuki Hiramatsu, Monique E. Cho, Alexandra Berger, Asada Leelahavanichkul, Kent Doi, Lakhmir S. Chawla, Gabor G. Illei, Jeffrey B. Kopp, James E. Balow, Howard A. Austin, Peter S.T. Yuen, Robert A. Star - Kidney International 2008 被引用: 277

  13. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

    著者: Dimitrios T. Boumpas, George P. Chrousos, Ronald L. Wilder, Thomas R. Cupps, James E. Balow - Annals of Internal Medicine 1993 被引用: 779

  14. Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

    著者: Mark F. Gourley, Howard A. Austin III, Dorothy Scott, Cheryl H. Yarboro, Ellen M. Vaughan, Joanne Muir, Dimitrios T. Boumpas, John H. Klippel, James E. Balow, Alfred D. Steinberg - Annals of Internal Medicine 1996 被引用: 610

  15. Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis

    著者: Gabor G. Illei, Howard A. Austin, Marianna Crane, Lee Collins, Mark F. Gourley, Cheryl Yarboro, Ellen M. Vaughan, Takashi Kuroiwa, Carol L. Danning, Alfred D. Steinberg, John H. Klippel, James E. Balow, Dimitrios T. Boumpas - Annals of Internal Medicine 2001 被引用: 495

  16. Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

    著者: Howard A. Austin, Gabor G. Illei, Michelle Braun, James E. Balow - Journal of the American Society of Nephrology 2009 被引用: 298

  17. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

    著者: Dimitrios T. Boumpas, H A Austin, James E. Balow, Ellen M. Vaughan, Cheryl Yarboro, John H. Klippel, A D Steinberg - The Lancet 1992 被引用: 827

  18. Prognostic factors in lupus nephritis

    著者: Howard A. Austin, Larry R. Muenz, Kathleen Joyce, Tatiana A. Antonovych, Margarita E. Kullick, John H. Klippel, John L. Decker, James E. Balow - The American Journal of Medicine 1983 被引用: 772

  19. Natural History of Fabry Renal Disease

    著者: Mary H. Branton, Raphael Schiffmann, Sharda G. Sabnis, Gary J. Murray, Jane M. Quirk, Gheona Altarescu, Lev G. Goldfarb, Roscoe O. Brady, James E. Balow, Howard A. Austin, Jeffrey B. Kopp - Medicine 2002 被引用: 462

  20. Chronic granulomatous disease as a risk factor for autoimmune disease

    著者: Suk See De Ravin, Nora Naumann, Edward W. Cowen, Julia C. Friend, Dianne Hilligoss, Martha Marquesen, James E. Balow, Karyl S. Barron, Maria L. Turner, John I. Gallin, Harry L. Malech - Journal of Allergy and Clinical Immunology 2008 被引用: 227

  21. Acyclovir-induced renal failure

    著者: Mark H. Sawyer, David E. Webb, James E. Balow, Stephen E. Straus - The American Journal of Medicine 1988 被引用: 222

  22. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever

    著者: Eran Pras, Avi Livneh, James E. Balow, Elon Pras, Daniel L. Kastner, Mordechai Pras, Pnina Langevitz - American Journal of Medical Genetics 1998 被引用: 283

  23. Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies

    著者: Rana Malek, Angeline Y. Chong, Beatrice Lupsa, Andreea O. Lungu, Elaine Cochran, Maria A. Soos, Robert K. Semple, James E. Balow, Phillip Görden - The Journal of Clinical Endocrinology & Metabolism 2010 被引用: 115

  24. miR-150 Promotes Renal Fibrosis in Lupus Nephritis by Downregulating SOCS1

    著者: Hua Zhou, Sarfaraz Hasni, Paola Pérez, Mayank Tandon, Shyh-Ing Jang, Changyu Zheng, Jeffery B. Kopp, Howard A. Austin, James E. Balow, Ilias Alevizos, Gabor G. Illei - Journal of the American Society of Nephrology 2013 被引用: 190